Purpose the aim of this retrospective study was to estimate risk organ doses and to estimate radiation risks during the imaging work-up and treatment for aneurysmal subarachnoid hemorrhage (SaH). Methods the imaging procedures comprised computed tomography and digital subtraction angiography studies for diagnosis or endovascular interventional procedures in 50 consecutive patients. equivalent organ doses (H t ) to skin, brain, eye lens, salivary glands, thyroid and oral mucosa were measured using thermoluminescence dosimeters in an anthropomorphic head phantom. Picture archiving and communication system (PacS) and radiological information system (riS) records were analyzed and the frequency of each imaging procedure was recorded as well as the registered individual kerma-length product (P Kl ) and the kerma-area product (P Ka ). the doses were computed by multiplying the recorded P Kl and P Ka values by the conversion coefficients H t /P Kl and H t /P Ka from the head phantom. Results the mean fluoroscopy time, P Kl and P Ka were 38 min, 7269 mgy cm and 286 gy cm 2 , respectively. the estimated mean equivalent doses were as follows: skin 2.51 Sv, brain 0.92 Sv, eye lens 0.43 Sv and salivary glands 0.23 Sv. Maximum organ doses were 2.3-3.5 times higher than the mean. interventional procedures contributed 66 % to skin dose, 55 % to brain dose and 25 % to eye lens dose. Of the patients with an estimated skin dose exceeding 6 Sv, only 1 developed temporary epilation. Conclusion the risk for radiation-induced cancer for SaH patients is low (2-3 cases per 1,000 patients, of which 90 % are expected to be benign types) compared with the risk of tissue reactions on the head such as skin erythema and epilation (1 temporary epilation per 50 patients).
Introduction
Subarachnoid hemorrhage (SaH) resulting from rupture of an intracranial saccular aneurysm has been found to occur with a frequency of between 8.1 and 23 per 100,000 in community-based studies, most commonly in patients aged 40-60 years (mean age about 50 years) and is 1.6 times more frequent in women than in men. in spite of considerable advances in diagnostic methods, endovascular and surgical techniques and perioperative management, aneurysmal SaH is still a devastating condition, with population-based mortality rates as high as 45 % and significant morbidity among survivors [1] .
technological advancements in medical imaging has improved diagnostics and made endovascular therapy possible and also resulted in decreased mortality and morbidity but also in patients with aneurysmal SaH receiving more medical radiation centered on the head than ever before. even if the "as low as reasonably achievable" (alara) concept of using only enough radiation to obtain images of sufficient quality for diagnosis or intervention is respected in individual imaging studies, the cumulative biological effects of increased number and complexity of x-ray-based medical imaging sessions in the first 2 weeks after SaH may become a concern for survivors. the radiation risks are acute (deterministic) radiation effects (tissue reactions) as defined by the international commission on radiological Protection (icrP, [2] ) and radiation-induced cancer (stochastic risk, [3] ). assessment of these biological effects is particularly important when new imaging techniques, such as computed tomography (ct) perfusion for the evaluation of cerebral blood flow in patients with vascular disorder [4] are established. in view of the revised recommendations by the icrP [5] including consideration of the detriment arising from non-cancer effects of radiation on health, it is essential to optimize radiological protection to minimize tissue reactions, such as skin erythema, temporary epilation and late manifested eye lens reactions. according to the icrP [2] acute radiation doses delivered to tissues during a single procedure or closely spaced procedures in time, may cause erythema or cataract at 2 Sv (organ equivalent dose), permanent epilation at 7 Sv and delayed skin necrosis at 12 Sv.
gelfand and Josephson [6] estimated effective doses to patients with SaH but did not estimate internal organ doses, which may be essential as the dose gradient can be large during the intervention but also in ct. Mamourian et al. [7] and Moskowitz et al. [8] measured the dose to the skin of SaH patients. However, neither of these studies estimated both skin dose and internal organ dose to organs at risk, such as the brain, salivary glands, oral mucosa and thyroid using a range of different imaging equipment for which tabulated organ doses are not readily available.
this retrospective study was conduced in a geographically well-defined population setting of 50 sequential patients with ruptured intracranial saccular aneurysms treated with endovascular techniques. the aim was to estimate
• the cumulative doses to organs at risk (skin, brain, salivary glands, oral mucosa, eye lens and thyroid) by both interventional and ct procedures during the acute, imaging-intensive phase of the therapy for aneurysmal subarachnoid hemorrhage and • to estimate short and long-term radiation effects.
Materials and Methods

Study Population
the Department of neurosurgery at linköping University Hospital provides all neurosurgical care to a population of 994,033 in south-eastern Sweden. a total of 50 consecutive patients with SaH caused by ruptured intracranial saccular aneurysms, which were occluded using endovascular coiling to avoid re-bleeding, were treated at the neurosurgical intensive care Unit (nSicU) after hemorrhage before discharge to local hospitals for continued medical treatment and rehabilitation. the management protocol included ultra-early patient referral (usually within 1-2 h) from local hospitals after diagnosis of SaH, short-term antifibrinolytic treatment (tranexamic acid), ct of the head, repair of the ruptured aneurysm as early as logistically feasible and intensive care. all patients were admitted to the nSicU for prevention and management of hydrocephalus, cerebral vasospasm, ischemia and systemic complications. transcranial Doppler (tcD) monitoring of the blood flow velocities in the middle cerebral arteries was done on a daily basis. Decision of whether to use external ventriculostomy, induced hypervolemia, hemodilution and hypertension was taken on individual merits for each case.
Diagnostic imaging Work-Up the routine imaging work-up included ct on arrival at the emergency ward for SaH diagnosis and computed tomographic angiography (cta) for aneurysm diagnosis and 3D depiction. Digital subtraction angiography (DSa) was used instead of cta for aneurysm diagnosis in some cases, ct was performed within 1 day of aneurysm repair in most cases and was repeated as necessary in cases with clinical deterioration and in most cases at discharge from the nSicU. all sedated patients underwent a head ct scan 4-12 h after aneurysm occlusion and ct was carried out on follow-up when hydrocephalus development was suspected. Quantitative studies of cerebral blood flow (cBF) using xenon (Xe) computerized tomography (Xe-ct) was performed in patients with suspected vasospasm and to monitor cBF for decision-making in unconscious patients with established severe vasospasm [9, 10] . On arrival ct and cta were performed using a conventional ct scanner (general electric lightspeed 16 and lightspeed Ultra 8, Piscataway, nJ). During nSicU care, bedside ct and Xe-ct were performed using a mobile ct scanner (ceretom, neurologica, Boston, Ma).
Digital Subtraction angiography and endovascular Procedures
Digital subtraction angiography and endovascular procedures were performed on a biplane angiography system (artis Ba or artis zee Biplane twin, with additional support of a workstation Syngo X Workplace; from Siemens, erlangen, germany) with 3D rotational angiography (3D ra) capability (in the case of artis zee Biplane twin also with flat detector c-arm volume acquisition or Dynact). endo-vascular aneurysm coiling was carried out in accordance with previously described techniques [11] . endovascular coiling alone, balloon-assisted coiling or stent-assisted coiling was performed as necessary. imaging during the coiling procedure included 3D rotational angiography in the cases when cta was not done before, when the cta study was unsatisfactory for planning the procedure or for use in 3D road-mapping (iPilot function) when demanded by the complexity of the aneurysm [12] . the Dynact was done either before treatment in patients who were under general anesthesia on admission and who did not undergo repeated ct or cta in order to evaluate for re-bleeding or hydrocephalus development during transport from another hospital or directly after treatment when periprocedural re-bleeding or (based on pericallosal artery and deep cerebral vein topography) rapid progress of hydrocephalus was suspected (in this case an external ventriculostomy could be placed immediately). Patients with vasospasm were treated with intra-arterial injections of nimodipine associated with balloon angioplasty when necessary. nimodipine injections were administered in the internal carotid or vertebral artery presenting with vasospasm. For injection in the carotid circulation the angiography catheter was positioned as distal as necessary into the internal carotid artery to avoid reflux to the external carotid artery. For injection into the vertebral artery the catheter was positioned at the level of the vertebra ciii. nimodipine 0.2 mg/ml (nimotop ® , Bayer) was used for intra-arterial injection diluted in 0.9 % saline in the proportion 1:3; i.e. 1 mg nimodipine was diluted in 20 ml solution. nimodipine was injected in a coaxial connector through the angiography catheter in small boluses of 1 ml of the solution every 30 s. and was washed into the vessel by continuous infusion of saline and heparin (1,000 U/l). the target nimodipine dose for every treated vessel was 3 mg but lower doses (1-2 mg) were given in case of mild vasospasm. inotropic drugs were given i.v. as necessary during intra-arterial nimodipine treatment. a DSa run of the target vessel was done before and after nimodipine injection. Balloon angioplasty was carried out as necessary and according to standard techniques [13] and always as a complement to nimodipine injection in spastic segments of the carotid siphon, proximal middle cerebral artery (M1 and M2 segments), proximal anterior cerebral artery (a1 segment), basilar artery and proximal posterior cerebral artery (P1 and P2 segments). the balloon system used was the Hyperglide (Micro therapeutics, irvine, ca) size 4 × 10 mm in most of the cases and recently also size 3 × 10 mm when the carotid siphon was not the target vessel. Systemic heparinization was used to keep activated clotting time between 200 s and 250 s during balloon angioplasty. Heparinization was discontinued but not reversed at the end of the procedure. Dosimetry Protocol thermoluminescence dosimeters (tlD li 2 B 4 O 7 ) were used to estimate organ doses in patients and in an anthropomorphic phantom. Dosimeter readout followed a standard protocol for the laboratory using a rados Dosacus re-1 reader (rados technology, Oy, Finland). Before readout the dosimeters were post-annealed at 80 °c and readout was performed at 300 °c; 0.5 s preheat, 10.5 s heating and pulse counting and 10 s post-heating. the dosimeters were calibrated to measure (i) the superficial personal dose equivalent, Hp(0.07), using the iSO/iec n-40 spectrum, and (ii) the depth dose in soft tissue. the Hp(0.07) calibration is made at the national Dosimetry Standard laboratory of the Swedish radiation Safety authority and the depth dose calibration is derived from an internal calibrator (Dosacus calibrator, rados technology Oy) with a calibration traceable to the national Dosimetry laboratory of the radiation and nuclear Safety authority, Finland. the uncertainty in the calibration procedure was estimated to be less than 15 % with a 95 % confidence interval.
Patient and anthropomorphic Phantom Dosimetry internal organ doses cannot be measured directly in patients, so a female anthropomorphic phantom ([14] , body mass 55 kg, length 160 cm) was used to estimate the doses from ct and intervention procedures. absorbed doses in the risk organs of skin, brain, salivary glands, oral mucosa, thyroid and eye lens were estimated by positioning tlDs in the phantom where 2 or 4 dosimeters were positioned in at least 37 dedicated holes in the head phantom representing particular risk organs. Dosimeter positions for the eye lens (2 positions) and thyroid (2 positions) were already present in the phantom and new positions were created for the brain (22 positions), salivary glands (9 positions) and oral mucosa (5 positions) in consultation with a specialist in odontological imaging. in the phantom, the tissue/organ equivalent doses (H t ) were computed for these risk organs after they had been imaged with the same imaging protocol as for patients. the anthropomorphic head phantom was imaged with both flat-detector ct (Dynact) using the Siemens biplane angiography system, with two different conventional general electric computed tomography systems (ct, cta) and with one ceretom mobile ct system (ct, Xe-ct) at the nSicU. to simulate the interventional coiling procedure on the head phantom, a coiling procedure was mimicked and the phantom was exposed to both typical fluoroscopy and DSa series and the kerma-area product (P Ka ) was also recorded [15] . in the cta examination, measurement of the organ equivalent dose (H t ) was repeated 3 times and 3 radiological nurses performed these examinations on the phantom in order to estimate the uncertainty of the head phantom organ doses due to different staff performing the examination but using the same imaging protocol. the ct dose index (c vol ), kerma-length product P Kl , and kerma-area product P Ka from these phantom measurements are listed in table 1. in the Dynact imaging on the biplane unit, the rotation of the X-ray tube is only 220° resulting in lower equivalent doses on the anterior side of the head as the X-ray tube rotates under the phantom or patient neck which produces a fixed P Ka of 7973 µgy m 2 (or 80 gy cm 2 ). in the Xe-ct cBF examination, 4 separate 10 mm-wide sections of the brain were imaged using a c vol of 25.2 mgy and the series were repeated 8 times per session. a 10 mm-wide reference scan with c vol = 14.4 mgy was also performed. the conventional ct and cta examinations of the head phantom resulted in c vol and P Kl values as shown in table 1. note that the imaging protocol of ct brain uses a higher c vol in the cerebellum (40 mm scan length) than in the brain (88 mm scan length) as axial scanning was used here.
During the interventional coiling procedure, Dynact imaging was performed on some patients. the maximum skin and eye lens doses were measured using a headband holding eight pairs of tl dosimeters for ten patients. these measurements were performed using the same technique as described by Sandborg et al. [15] .
the hospital picture archiving and communication system (PacS) and radiological information system (riS) patient dose records were analyzed for the 50 patients starting from the time of admission to hospital for SaH and ending at discharge from nSicU. the individual patient dose records in terms of c vol , P Kl and P Ka were analyzed including all interventional and ct procedures during the study period. the individual patient organ equivalent doses were estimated by multiplying the P Kl and P Ka (from the PacS/riS dose records) by the H t /P Kl and H t /P Ka organ dose conversion coefficients from the anthropomorphic phantom measurement (see previous section) using the same imaging protocol and imaging equipment as with patients (table 1) .
Results
clinical results
the patients were 38 women and 12 men with a mean age of 54 years (SD ± 11.8, range 20-78 years). aneurysm sites and respective obliteration rates after endovascular treatment are summarized in table 2. the patient's clinical condition on arrival and outcome are summarized in table 3. Severity of SaH, evaluated on admission with the Hunt and Hess grade [16] was grade i in 19 patients, grade ii in 7, grade iii in 2 and grade iV in 1. a total of 59 aneurysms were treated (3 patients had 2 aneurysms and 3 patients had 3 aneurysms that were occluded in the same intervention). the most frequent aneurysm site was the anterior communicating artery (27 aneurysms or 45.7 %), mean aneurysm size was 5.8 mm (SD ± 3.2, range 2-19 mm) and 36 aneurysms (61 %) were wide-necked. all but 1 patient were treated within 72 h of SaH (one patient was treated 2 weeks after SaH, after developing secondary cerebral ischemia due to vasospasm). coiling alone was performed in 49 aneurysms (83 %), balloon-assisted coiling in 7 (11.9 %) and stent-assisted coiling in 3 (5.1 %). the coiling procedure included 3D ra in 19 cases and the volume acquisition was also used for 3D road-mapping (iPilot) in 7 of these cases but in only 1 case the lesion (a very small anterior communicating aneurysm) would not have been approachable using endovascular technique without this functionality. immediate aneurysm obliteration on DSa according to the Montréal scale [17] was complete obliteration in 30 aneurysms (50.8 %), a residual neck was present in 26 (44.1 %) and a residual aneurysm in 3 (5.1 %; none of the latter were ruptured aneurysms). there were two cases of procedure-related morbidity (4 %): One patient had a brain ischemic complication and one patient had an intraprocedural aneurysmal rupture during a DSa series done just after deployment of the first coil with a resulting intracerebral hematoma that was evacuated by craniotomy after completion of coiling of the aneurysm. the nSicU care period was in average 14.9 days (SD ± 11.66, range 3-89 days). the clinical outcome, rated according to the glasgow outcome scale (gOS, [18] ) at the latest follow-up evaluation (mean 7.5 months, SD ± 6.3, range 0.3-18 months) was a favorable outcome (gOS 4-5) in 40 patients, a poor outcome (gOS 2-3) in 4 patients, and death (gOS 1) in 6 patients. table 4 shows mean values of patient age, days in treatment, fluoroscopy time, kerma-area product, P Ka (including coiling procedure, treatment of vasospasm, DSa and Dynact imaging) and kerma-length product, P Kl (including all ct, cta, and Xe-ct). there is a considerable spread in the dosimetric results as indicated by the standard deviation of the mean, minimum and maximum values. With the exception of patient age, the median value is lower than the mean value. this is expected for a positive skewed distribution. the mean number of conventional ct or cta examinations of the head was 5.8 per patient during the study period. the corresponding number of Xe-ct was 2.0. the Dynact on the biplane angiography system was used on average 0.5 occasions per patient. X-ray examinations of other body parts numbered 1.9 per patient during the study period. these examinations were not on the head region but mainly the thorax (conventional chest x-ray examinations, ct scans of the thorax or of the cervical spine) and only contributed 0.1% and 0.6 % to the mean P Ka and P Kl values, respectively. these examinations were not included in the risk organ dose estimation. table 5 shows the risk organ dose conversion coefficients H t /P Kl and H t /P Ka for the phantom and patient tlD measurements. the coefficients of variation, cV, in the risk organ dose conversion factors for the cta examination are approximately 4 % for the brain and oral mucosa, 13 % for thyroid and eye lens, and 20 % for the salivary glands. Figure 1 and table 6 show the mean organ equivalent doses during the study period. the error bars associated with the organ equivalent doses in Fig. 1 are based on the measured variation in the conversion coefficients obtained [15] c Data from measurements of ten patients 
Organ Doses
Risk organ Equivalent organ doses (mSv)
from the three repeated measurements in the anthropomorphic phantom (table 5) . Here it was assumed that the same variation in the conversion coefficients found in the cta examination was valid in all four ct examinations. the largest percentage dose variation was found for the eye lens (11 %) and the smallest for the brain (2 %). this is reasonable as the eye lens is located close to the edge of the X-ray beam and the dose to the eye lens is mainly due to the ct examination and only to a smaller extent due to the coiling intervention. the dose to the brain is not likely to depend appreciably on small variations in head positioning by the radiological nurse because the imaging protocol is the same for all cta examinations and performed on the same ct scanner. table 6 shows that the skin receives the highest equivalent dose, followed by the brain, eye lens, salivary glands, oral mucosa and the thyroid. as can be seen from the standard deviation of the mean organ equivalent doses in table 4 and from data in Fig. 2 , the individual variation in equivalent doses from patient to patient is substantial depending on the individual imaging work-up. the highest doses to the skin, brain, and eye lens were 8.8 Sv, 2.8 Sv and 1.0 Sv, respectively. Figure 2 shows the variation in organ equivalent doses for the 50 patients in the study. Patients 23, 29-31, 36 and 48 died from the disease and 3 of these patients (23, 29, and 36) had among the largest cumulative equivalent doses. Of the ten patients with the largest cumulative equivalent doses nine had more than or equal to 15 ct or Xe-ct examinations during the study period. Figure 3 shows the mean organ equivalent doses to skin, brain, eye lens, and salivary glands and the corresponding percentages of the respective doses from each type of procedure. the brain received 55 % of organ dose from the interventional procedures (including Dynact) and 35 and 10 % from the ct and Xe-ct procedures, respectively. the eye lens, however, received only 25 % of the organ dose from the interventional procedure (including Dynact) and 71 and 4 % from the ct and Xe-ct procedures, respectively. Most of the skin dose (66 %) is due to the interventional procedures.
risk assessment there are two risk scenarios associated with significant irradiation of patients: the risk for radiation-induced cancer and that for tissue reactions such as skin erythema, epilation and eye lens opacity or cataract.
the incidence risk for nervous system tumors has been thoroughly evaluated by Preston et al. [19] and thompson et al. [20] . their evaluations on cancer incidence for atomic bomb survivors in the extended life Span Study (lSSe85), a cohort of about 80,000 people, give crude cancer incidence rates by dose and number of excess nervous system tumors. Based on their data an absolute excess risk of about 0.002-0.003/Sv was derived. Schwannomas account for about 65 %, meningioma about 20 % and glioma plus astrocytoma approximately 10 % of the expected excess cases [19] . the corresponding risk for pituitary tumors is approximately 10 % of the risk for nervous system tumors [19] . With a mean dose to the brain of 0.92 Sv, the theoretical risk of induction of nervous system tumors is about 0.2-0.3 %, i.e. 2-3 cases per 1,000 procedures, of which approximately 90 % are expected to be benign tumors. the corresponding risk of induction of thyroid and oral cavity cancers, also derived from atomic bomb survivor data [20, 21 ] is 1-2 orders of magnitude lower, as expected from the much lower organ dose levels.
the maximum eye lens dose (1004 mSv) is less than the threshold dose for lens cataract or lens opacity according to the icrP [2] but higher than the threshold dose of 0.5 Sv for late eye lens reactions recently suggested by the icrP [5] . among the patients reported here 17 (34 %) had an estimated eye lens dose exceeding 0.5 Sv. the estimated maximum skin dose of 8.8 Sv found here substantially exceeds the threshold of early temporary epilation (3 Sv) and also the threshold for permanent hair loss (7 Sv) . in this study 14 (28 %) exceeded the 3 Sv threshold, 3 patients (6 %) exceeded the 7 Sv threshold but none the 12 Sv threshold for delayed skin necrosis. However, of these three patients with the highest estimated maximum skin dose, two died from the disease. among the three surviving patients with the highest estimated radiation doses only 1 (2 %) developed temporary epilation (patient #27, a 50-year old woman who underwent 15 ct or Dynact examinations, P Ka = 758 gy cm 2 , P Kl = 11439 mgy cm, H t,skin = 6.5 Sv, H t,brain = 2.1 Sv).
Discussion
limitations of this Study
Patient doses were not measured directly by using a dosimeter on each patient's head, as was undertaken for example by Mamourian et al. [7] in their prospective study. in this presented retrospective study, however, a larger number of patients were included and advantage was taken of the very detailed individual PacS and riS patient dose records and anthropomorphic phantoms were used to mimic real ct and coiling procedures for estimation of organ equivalent doses in internal organs as well. in doing so the maximum skin dose might have been overestimated as the maximum skin doses from all imaging procedures individually were accumulated. it is possible that the maximum skin dose from several X-ray examinations does not coincide in the same area on the patient's head, which would lead to an overestimation of the maximum skin dose.
the incidence risk for nervous system tumors used here for the SaH patients should be taken as a rough estimate as it does not consider risk modifications such as gender, age at exposure and attained age. the mean age of the exposed group of the lSS cohort was 40.7 years which is lower than that of this study group (53.8 years) and indicates an overestimation of the risk for the SaH patients. the majority of the patients were female.
comparison with the literature in endovascular procedures radiation dose to the patient depends on the interventionist's experience, the number of DSa runs, fluoroscopy time and technique parameters (pulse rate, dose per pulse, tube current/tube potential modulation and added cupper filtration). in computed tomography, technical features of the ct scanner, such as tube current modulation, tube potential and image quality settings (quality reference ma, noise index etc.) influence the c vol and P Kl . these factors have to be taken in consideration in future comparisons to the data.
the mean kerma-area product (P Ka ) in this study (283 gy cm 2 ) was larger than that in the previous study [15] that was 121 gy cm 2 . However, only 44 % or 123 gy cm 2 of the kerma-area product is due to the coiling procedure, 113 gy cm 2 is due to treatment of vasospasm including a DSa and 47 gy cm 2 is due to the Dynact procedure. Hence the P Ka from the coiling procedure alone is in fact identical to the results from the previous study but lower than reported by Kemerink et al. [22] (228 gy cm   2 ). However, in this study (in contrast to Sandborg et al. [15] ) the estimated maximum skin doses were higher (table 6) as skin doses due to ct examinations during patient stay at the nSicU were also included.
cohnen et al. [23] estimated organ doses with an anthropomorphic phantom and tlDs using a similar strategy as in this work for standard ct of the head and for ct angiography. the ratio between the organ dose and kerma-length product H t /P Kl for the brain (0.064 mSv/mgy cm) is similar to that found in this study (table 5) in the ct brain examination. However, the corresponding P Kl -normalized organ doses differ from those for the eye lens and the thyroid: in this study this was lower for the thyroid but higher for the eye lens. the dose to the eye lens depends on the setup of each patient's head in the ct gantry and whether or not the gantry is angled away from the eye lens.
Suzuki et al. [24] measured skin dose during neuroembolization using a mesh of 44 radiosensitive indicators on the patient's head. the mean P Ka was 255 gy cm 2 and the estimated mean maximum entrance skin dose was 1.9 gy. their data were slightly higher than the mean maximum skin dose in this survey (1.7 gy) from the interventional coiling (including Dynact) procedure even though the P Ka = 286 gy cm 2 was similar. However, Suzuki et al. [24] suggested that measurement of maximum skin dose with tl dosimeters is likely to underestimate the maximum skin dose owing to the limited number of data points.
Mamourian et al. [7] measured the cumulated skin dose in 12 patients admitted with SaH using a self-developing film badge placed behind the right ear. they found good correlation between the measured dose and the number of ct examinations and length of stay in the intensive care unit (icU). the mean dose for patients with interventional treatment was 0.9 gy with a maximum of 1.8 gy for one patient who had ten ct scans. the results of this study suggest that the maximum skin dose can be higher as the mean maximum skin dose was 2.5 Sv in this study where 17 (34 %) patients underwent more than 10 ct or Dynact imaging procedures. a large fraction of the skin dose is due to the coiling procedure (see Fig. 3 ) and the maximum skin dose is therefore likely to be located on the back of a patient's head.
Moskowitz et al. [8] estimated that the mean cumulative dose to the cranium during hospitalization was 12.8 gy (range 2.4-36.1 gy), which is approximately 5 times higher than the mean maximum skin dose in this study. However, Mamourian et al. [25] have raised some doubts over the data analysis in the work by Moskowitz et al. [8] .
gelfand and Josephson [6] reported a mean effective dose of 80 mSv for 20 SaH patients who had multiple exposures to their head from ct, cta, cerebral angiography and interventions. the estimated mean effective dose, based on organ doses to risk organs measured in this study was 13 ± 9 mSv (range 3-39 mSv) using the icrP [21] tissueweighting factors (w t ). However, the effective dose based on the previous compilation of w t from year 1991 [26] was approximately 1.8 times higher as the brain would then be a so-called remainder organ with a high dose and as such receive a higher tissue-weighting factor (w brain = 0.025) than when using icrP [21] w brain = 0.01. the use of the effective dose concept in such a small population and with only a small part of the body exposed to high doses is however debatable.
Magrassi et al. [27] estimated the maximum skin dose in 107 consecutive patients with neuroembolization and found that 22 patients developed partial epilation on average 4 weeks after the procedure. this corresponds to one case of epilation in five neuroembolizations which is a more frequent occurrence compared to this study. However, their follow-up strategy for tissue reactions was more careful than in this study but their median P Ka (957 gy cm 2 ) was higher than the corresponding 95 % percentile value (809 gy cm 2 ) in this study. From their extensive literature study, the average maximum skin dose at which epilation developed was 4.2 gy (range 2.0-6.6 gy), indicating that, as in this study, tissue reactions do occur following justified, high-dose procedures.
importance from a clinical Perspective as a large proportion of the patients (80 %) made a good recovery or had moderate disability on follow-up, the risk for developing tissue reactions may be a matter of concern. However, aneurysmal subarachnoid hemorrhage is a life-threatening condition and in the process of obtaining informed consent from the patient or family for treatment it would be unreasonable to emphasize the potential deterministic and especially the stochastic effects of the radiation dose involved. radiation effects are not observed in most patients. On the other hand an uninformed patient may not know whom to turn to in the event of skin erythema or temporary epilation in the weeks following treatment. One strategy can be to provide some general information to patients and to assess the occurrence of skin reaction as part of the clinical follow-up, in particular to those individuals who are more likely to develop tissue reactions owing to a high dose at the interventional reference point (> 4,000 mgy) from the interventional examination or who have had more than 15 ct examinations (10 % of the patients in this study). replacement of ct with Mri is not realistic as a method for dose reduction in patients in the acute phase of aneurysmal SaH because of the risks inherent in the transport of severely ill, multimodality monitored patients and the fact that ct scans can be obtained at the bedside [28] . the radiation dose during the endovascular procedures represents only a minor proportion of the total radiation dose during hospitalization for aneurysmal SaH and the possibilities to reduce periprocedural doses are limited: the kermaarea product was on average only 123 gy cm 2 in the coiling procedures alone (including the radiation coming from 3D ra but excluding that from Dynact, when used). a relationship between aneurysm complexity and radiation dose is intuitively expected to occur in elective cases involving long procedures using a combination of balloon-assisted technique, stents and coiling. However, this kind of procedure is usually not the case when ruptured aneurysms are repaired because the use of antiplatelet medication is imperative. in this centre microsurgery is the first choice method for repair of very complex ruptured aneurysms and a partial coiling procedure that is empirically enough to avoid re-bleeding is done when microsurgery is considered a less efficient method for the particular situation. Stent-assisted coiling is used in patients with acute SaH only in exceptional cases: in this series two of the three patients treated with stent-assisted coiling had complex aneurysms but only mild SaH without hydrocephalus in the first ct scan; the lesion was considered not approachable by microsurgery and partial coiling alone could not be done in the third case and that patient had a fatal outcome.
Conclusions
the mean skin, brain and eye lens doses were 2.5 Sv, 1.00 Sv, and 0.40 Sv, respectively but individual patient maximum doses were up to 2.3-3.5 times higher with some well above the threshold for deterministic effects. the theoretical risk for radiation-induced cancer for SaH patients is low (2-3 cases per 1,000 patients) of which approximately 90 % are expected to be benign. the risk of tissue reactions on the head, such as skin erythema and epilation (1 temporary epilation per 50 patients) is higher.
